SEARCH

SEARCH BY CITATION

References

  • 1
    Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med 1992; 152: 16604.
  • 2
    Nordström M, Lindblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992; 232: 15560.
  • 3
    Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population based cohort study. Arch Intern Med 1998; 158: 58593.
  • 4
    Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 116773.
  • 5
    Briggs JB. Recurring phlebitis of obscure origins. Bull Johns Hopkins Hosp 1905; 16: 228–233.
  • 6
    Souto JC, Almasy L, Borrell M, Blanco-Vaca F, Mateo J, Soria JM, Coll I, Felices R, Stone W, Fontcuberta J, Blangero J. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Am J Hum Genet 2000; 67: 14529.
  • 7
    Heit JA, Phelps MA, Wared SA, Slusser JP, Petterson TM, de Andrade M. Familial segregation of venous thromboembolism. J Thromb Haemost 2004; 2: 7316.
  • 8
    Larsen TB, Sörensen HT, Skytthe A, Johnsen SP, Vaupel JW, Christensen K. Major genetic susceptibility for venous thromboembolism in men: a study of Danish twins. Epidemiology 2003; 14: 32832.
  • 9
    Zöller B, Garcia de Frutos P, Hillarp A, Dahlbäck B. Thrombophilia as a multigenic disease. Haematologica 1999; 84: 5970.
  • 10
    Briët E, van der Meer FJ, Rosendaal FR, Houwing-Duistermaat JJ, van Houwelingen HC. The family history and inherited thrombophilia. Br J Haematol 1994; 87: 34852.
  • 11
    Cosmi B, Legnani C, Bernardi F, Coccheri S, Palareti G. Value of family history in identifying women at risk of venous thromboembolism during oral contraception: observational study. BMJ 2001; 322: 10245.
  • 12
    Aznar J, Mira Y, Vaya A, Ferrando F, Villa P. Is family history sufficient to identify women with increased risk of venous thromboembolism before commencing the contraceptiive pill? Clin Appl Thromb Hemost 2002; 8: 13941.
  • 13
    van Sluis GL, Söhne M, El Kheir DY, Tanck MW, Gerdes VE, Büller HR. Family history and inherited thrombophilia. J Thromb Haemost 2006; 4: 21827.
  • 14
    Dietrich J, Hertweck P, Perlman SE. Efficacy of family history in determining thrombophilia risk. J Pediatr Adolesc Gynecol 2007; 20: 2214.
  • 15
    Bezemer ID, van der Meer FJM, Eikenboom JCJ, Rosendaal FR, Doggen CJM. The value of family history as a risk indicator for venous thrombosis. Arch Intern Med 2009; 169: 61015.
  • 16
    Gohil R, Peck G, Sharma P. The genetics of venous thromboembolism. A meta-analysis involving 120,000 cases and 180,000 controls. Thromb Haemost 2009; 102: 36070.
  • 17
    Rosendaal FR, Reitsma PH. Genetics of venous thrombosis. J Thromb Haemost 2009; 7(Suppl. 1): 3014.
  • 18
    Noboa S, Le Gal, Lacut K, Mercier B, Leroyer C, Nowak E, Mottier D, Oger E, for the EDITH Collaborative Study Group. Family history as a risk factor for venous thromboembolism. Thromb Res 2008; 122: 6249.
  • 19
    Dowling NF, Austin H, Diley A, Whitsett C, Evatt BI, Hooper WC. The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study. J Thromb Haemost 2003; 1: 8087.
  • 20
    Hemminki K, Shu X, Li X, Ji J, Sundquist J, Sundquist K. Familial risks for hospitalization with endocrine diseases. J Clin Endocrinol Metab 2008; 93: 47558.
  • 21
    Sundquist K, Li X, Hemminki K. Familial risk of ischemic and hemorrhagic stroke. A large-scale study of the Swedish population. Stroke 2006; 37: 166873.
  • 22
    Hemminki K, Li X, Sundquist J, Sundquist K. Familial risks for type 2 diabetes in Sweden. Diabetes Care 2010; 33: 2937.
  • 23
    Hemminki K, Li X, Sundquist J, Sundquist K. The epidemiology of Graves’ disease: evidence of a genetic and an environmental contribution. J Autoimmun 2010; 34: J30713.
  • 24
    Bucciarelli P, Rosendaal FR, Tripodi A, Mannucci PM, De Stefano V, Palareti G, Finazzi G, Baudo F, Quintavalla R. Risk of venous thrombosis and clinical manifestations in carriers of antithrombin, protein C; protein S deficiency, activated protein C resistance: a multicenter collaborative family study. Arterioscler Thromb Vasc Biol 1999; 19: 102633.
  • 25
    Engesser L, Broekmans AW, Briét E, Brommer EJ, Bertina RM. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 1987; 106: 67782.
  • 26
    Zöller B, Berntsdotter A, Garcia de Frutos P, Dahlbäck B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 1995; 85: 351823.
  • 27
    Rothman KJ, Greenland S. Modern Epidemiology, 2nd edn. Philadelphia, PA: Lippincott-Raven, 1998.
  • 28
    Hemminki K, Vaittinen P, Dong C, Easton D. Sibling risks in cancer: clues to recessive or X-linked genes? Br J Cancer 2001; 84: 38891.
  • 29
    National Cancer Institute, US National Institutes of Health. Surveillance epidemiology and end results: standard populations (millions) for age adjustments. http://seer.cancer.gov/stdpopulations/. Accessed 1 February 2010.
  • 30
    Parasuraman S, Goldhaber SZ. Venous thromboembolism in children. Circulation 2006; 113: e1216.
  • 31
    Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, Bernstein M, Brisson L, Cairney B, DeSai D, Grant R, Israels S, Jardine L, Luke B, Massicotte P, Silva M. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994; 83: 12511257.
  • 32
    Trégouet DA, Heath S, Saut N, Biron-Andreani C, Schved JF, Pernod G, Galan P, Drouet L, Zelenika D, Juhan-Vague I, Alessi MC, Tiret L, Lathrop M, Emmerich J, Morange PE. Common susceptibility alleles are unlikely to contribute as strongly as the FV and AB0 loci to VTE risk: results from a GWAS approach. Blood 2009; 113: 5298303.
  • 33
    Socialstyrelsen. Patientregistret 1987–1996 Kvalitet Och Innehåll. Stockholm: Epidemiologiskt Centrum, Socialstyrelsen, 1998.
  • 34
    Rosengren A, Fredén M, Hansson P-O, Wilhelmsen L, Wedel H, Eriksson H. Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost 2008; 6: 55864.
  • 35
    Petrauskiene V, Falk M, Waernbaum I, Norberg M, Eriksson JW. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia 2005; 48: 101721.
  • 36
    Isma N, Svensson PJ, Gottsäter A, Lindblad B. Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS). Thromb Res 2009; 124: 6636.
  • 37
    Isma N, Svensson PJ, Gottsäter A, Lindblad B. Upper extremity deep venous thrombosis in the population-based Malmö Thrombophilia Study (MATS). Epidemiology, risk factors, recurrence risk, and mortality. Thromb Res 2010; 125: e3358.
  • 38
    Hammar N, Alfredsson L, Rosen M, Spetz CL, Kahan T, Ysberg AS. A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int J Epidemiol 2001; 30: S304.
  • 39
    Lindblad U, Råstam L, Ranstam J, Peterson M. Validity of register data on acute myocardial infarction and acute stroke: the Skarborg Hypertension Project. Scand J Soc Med 1993; 21: 39.
  • 40
    The National Board of Health and Welfare. Validity of the diagnoses from the Swedish In-Care Register 1987 and 1995 (in Swedish). Epidemiologiskt Centrum, Socialstyrelsen 2000.
  • 41
    Johansson LA, Westerling R. Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics. Int J Epidemiol 2000; 29: 495502.
  • 42
    White R. The epidemiology of venous thromboembolism. Circulation 2003; 107: I48.
  • 43
    Heit JA, Silverstein MD, Mohr DN, Petterson TM, Lohse CM, O’Fallon WM, Melton J. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86: 45263.
  • 44
    Allart CF, Poort SR, Reitsma PH, Bertina RM, Briët E, Rosendaal FR. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993; 341: 1348.
  • 45
    Couturaud F, Leroyer C, Julian JA, Kahn SR, Ginsberg JS, Wells PS, Douketis JD, Mottier D, Kearon C. Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism. Chest 2009; 136: 153745.